$ARIA Recent Headlines

New Post Public Reply Private Reply Replies (0) Message Board

Sep 24, 2014 at 10:35 AM

$ARIA Recent Headlines

Six stocks to watch
4:27 p.m. Feb. 26, 2014
- The Trading Deck

6 stocks to watch
4:34 p.m. Feb. 12, 2014
- The Trading Deck

Ariad falls after wild ride upward, while Care.com holds on to its gains

10:02 p.m. Jan. 27, 2014
- Russ Britt

Apple green ahead of earnings; Caterpillar tops gainers
4:42 p.m. Jan. 27, 2014
- Sue Chang

Ariad shares jump nearly 30% on rumors of Big Pharma takeover

2:43 p.m. Jan. 24, 2014
- Russ Britt

5 charts to watch
4:52 p.m. Jan. 15, 2014
- The Trading Deck

Apple closes lower; B. of A. rises on analyst call
5:15 p.m. Jan. 2, 2014
- Wallace Witkowski

Apple gains on China Mobile deal; homebuilders rally
4:33 p.m. Dec. 23, 2013
- Wallace Witkowski

Suspension is lifted for Ariad's leukemia drug
7:33 a.m. Dec. 23, 2013
- MarketWatch.com

J.C. Penney and more of the year's most profitable shorts

4:23 p.m. Dec. 9, 2013
- blogs.marketwatch.com

Hewlett-Packard, a cyclical green light and why silver is in trouble

9:50 a.m. Nov. 26, 2013
- Shawn Langlois

Ariad takes another pounding after leukemia treatment is pulled

1:14 p.m. Oct. 31, 2013
- Russ Britt

H-P has best day in four months on upbeat outlook
4:34 p.m. Oct. 9, 2013
- Sue Chang

Ariad plummets 70% after drug test patients have serious clotting issues

11:38 a.m. Oct. 9, 2013
- Russ Britt

FDA places partial hold on Ariad's Iclusig trials
8:16 a.m. Oct. 9, 2013
- MarketWatch.com

Dan Loeb makes bet on Disney
8:06 p.m. Aug. 14, 2013
- David Benoit

Onyx share surge lifts several boats in biotech harbor, including ETFs

11:33 a.m. July 1, 2013
- Russ Britt

SAC Capital Advisors likes this pharma stock
4:24 p.m. April 18, 2013
- Insider Monkey

Ariad Pharma up 6% to $20.09
11:35 a.m. Dec. 17, 2012
- Steve Gelsi

FDA OKs Iclusig to treat rare types of leukemia
2:06 p.m. Dec. 14, 2012
- MarketWatch.com

Amgen Files Blinatumomab Marketing Application in U.S. - Analyst Blog

5:55 p.m. Sept. 23, 2014
- Zacks.com

Ariad Director Resignation May Mean CEO Berger One Step Closer to Exit

12:05 p.m. Sept. 19, 2014
- TheStreet.com

InsiderInsights.com Daily Round Up 9/11/14: LULU, ARIA, TITN, RSG

9:58 a.m. Sept. 12, 2014
- Seeking Alpha

Biggest Movers in Healthcare Stocks Now – ISIS ARIA ACAD ALNY

8:00 a.m. Sept. 12, 2014
- InvestorPlace.com

Biotech Stock Mailbag: Achillion, Ariad Revisited, Endocyte

8:55 a.m. Sept. 5, 2014
- TheStreet.com

Biggest Movers in Healthcare Stocks Now – CLDX ARIA CNC ZMH

7:45 a.m. Sept. 4, 2014
- InvestorPlace.com

'Mad Money' Lightning Round: Yahoo! Is One of the Best Buys Around

6:00 a.m. Sept. 4, 2014
- TheStreet.com

Cramer's Lightning Round - Yahoo Is A Good Steward Of Capital (9/3/14)

5:40 a.m. Sept. 4, 2014
- Seeking Alpha

Jim Cramer's 'Mad Money' Recap: These Are 3 Stocks Cramer Trusts

8:17 p.m. Sept. 3, 2014
- TheStreet.com

Biggest Movers in Healthcare Stocks Now – CYH ARIA THC LUX

8:15 a.m. Aug. 29, 2014
- InvestorPlace.com

Biotechs With Insider Buying

2:16 p.m. Aug. 22, 2014
- Seeking Alpha

Hottest Healthcare Stocks Now – ARIA CELG LCI RDY

9:15 a.m. Aug. 20, 2014
- InvestorPlace.com

InsiderInsights.com Daily Round Up: 8/19/14

3:36 a.m. Aug. 20, 2014
- Seeking Alpha

Hottest Healthcare Stocks Now – PTCT LGND WX BIIB

1:45 p.m. Aug. 15, 2014
- InvestorPlace.com

ARIAD Falls on Wider-than-Expected Loss, Revenues Miss - Analyst Blog

12:21 p.m. Aug. 11, 2014
- Zacks.com

Ariad Pharmaceuticals' (ARIA) CEO Harvey Berger on Q2 2014 Results - Earnings Call Transcript

5:30 p.m. Aug. 6, 2014
- Seeking Alpha

Why Ariad Pharmaceuticals (ARIA) Stock Is Down Today

1:07 p.m. Aug. 6, 2014
- TheStreet.com

Ariad updates guidance after Q2 results

8:51 a.m. Aug. 6, 2014
- Seeking Alpha

ARIAD Pharmaceuticals (ARIA) Q2 2014 Results - Earnings Call Webcast

8:25 a.m. Aug. 6, 2014
- Seeking Alpha

Notable earnings before Wednesday’s open

5:30 p.m. Aug. 5, 2014
- Seeking Alpha

INNATE PHARMA APPOINTS PIERRE DODION AS CHIEF MEDICAL OFFICER AND MEMBER OF THE EXECUTIVE COMMITTEE
12:41 p.m. Sept. 16, 2014
- GlobeNewswire

Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen
8:55 a.m. Sept. 4, 2014
- PR Newswire - PRF

Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024
1:19 p.m. Aug. 19, 2014
- PR Newswire - PRF

ARIAD Reports Second Quarter 2014 Financial Results and Development
Progress
11:34 p.m. Aug. 6, 2014
- BusinessWire - BZX

ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Israel
7:36 a.m. Aug. 5, 2014
- BusinessWire - BZX

Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma
9:00 a.m. Aug. 1, 2014
- PR Newswire - PRF

ARIAD to Webcast Conference Call on Second Quarter 2014 Financial
Results
7:35 a.m. July 16, 2014
- BusinessWire - BZX

ARIAD Announces Continuation of Iclusig Review under the Article 20
Procedure in Europe
7:35 a.m. July 14, 2014
- BusinessWire - BZX

Clinical Studies, Trials Results, Appointments, and Technical Updates - Analyst Notes on Ohr, Ariad, Arrowhead, CytRx and Karyopharm Therapeutics
5:00 a.m. June 27, 2014
- PR Newswire - PRF

Stock Watchout on Biotech Industry -- Research on ARIAD Pharma, Geron, Seattle Genetics, and Sarepta Therapeutics
7:30 a.m. June 26, 2014
- PR Newswire - PRF

ARIAD Announces Three Key Appointments to Its Global Management Team
7:35 a.m. June 23, 2014
- BusinessWire - BZX

ARIAD Announces Pricing of $200 Million Offering of 3.625%
Convertible Senior Notes Due 2019
9:15 a.m. June 12, 2014
- BusinessWire - BZX

ARIAD Announces Proposed $175 Million Offering of Convertible Senior
Notes Due 2019
4:01 p.m. June 11, 2014
- BusinessWire - BZX

ARIAD Announces Webcast of Its Annual Shareholders Meeting
7:35 a.m. June 11, 2014
- BusinessWire - BZX

Cohera Medical, Inc.® Appoints Richard W. Pascoe to its Board of Directors
6:00 a.m. June 4, 2014
- PR Newswire - PRF

ARIAD Announces Initial Data from Phase 2 Trial of Ponatinib in
Patients with Gastrointestinal Stromal Tumors
9:01 a.m. June 1, 2014
- BusinessWire - BZX

ARIAD Presents Updated Phase 1/2 Data on AP26113
in Patients with ALK+ Non-Small Cell Lung Cancer
2:16 p.m. May 31, 2014
- BusinessWire - BZX

Stocks Coverage on Biotech Equities -- Research on Gilead Sciences, ARIAD Pharma, Rexahn Pharma, and Geron
7:10 a.m. May 30, 2014
- PR Newswire - PRF

ARIAD to Present at Upcoming Investor Conferences
7:36 a.m. May 28, 2014
- BusinessWire - BZX

Clinical Trial Results, Development Collaboration, Board Appointments, Presentations, and Quarterly Results - Analyst Notes on Gilead, Questcor, Vertex, ARIAD and Puma Biotechnology
7:40 a.m. May 20, 2014
- PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Interventional Ophthalmology: Early Eye Care Strategies Evolve

Proactive Eye Care: The New Frontier Today's eye care landscape is all about catching things early, folks. Long gone are the days of waiting for eyesight to deteriorate before rushing to the nearest eye doc. In Racine, interventional ophthalmology is shifting gears towards preventive care—looking ahead to stop eye diseases in their tracks before they muck up a person's...

DoorDash Speeds Up Gifting: Same-Day Delivery Wins

Transforming Urgent Gift-Giving with Local Delivery Ever found yourself scrambling for a last-minute gift when time seems to be slipping away? That's where DoorDash steps up, changing the game with their same-day delivery options. In the fast-paced world we're living in, folks aren't just leaning on DoorDash for takeout anymore. They're pushing it as a lifeline for...

Intellectia.AI Transforming Trading with AI Upgrades

Intellectia.AI Sparks New Trading Era Intellectia.AI, from the bustling streets of New York, is cutting through the noise with a flashy update to its AI-powered trading setup. They've thrown a heap of new toys into the ring, letting folks piggyback on high-grade stock moves in the blink of an eye. Gone are the days of fumbling with cumbersome data and execution. Breaking...

Reliable Safety & Flow: A New Era in Infrastructure

Seismic Merger: Reliable Sprinkler and ASC Join Forces When two companies with roots stretching back to the 1800s decide to merge, it's not just a business move—it's a bold statement. Reliable Automatic Sprinkler and ASC Engineered Solutions, with over 175 years of combined innovation, have officially become Reliable Safety & Flow Corporation. This ain't just a...

Big Wins at Americas Cardroom's $15M Venom Series

High Stakes and Huge Paydays: The Venom Breakdown Alright, folks, here's a tale of how the cards fell in one of the most electrifying poker standoffs at Americas Cardroom. With prize pools clocking in at a staggering $15.095 million, the Dual Mystery Bounty Venoms really stacked the chips high. From the gritty, bustling halls of the internet to the proverbial green-felt...

Hims & Hers Health Hit by FTC Claims and Class Action

Hims Faces Harsh Lessons With FTC Lawsuit There's trouble brewing in the world of telehealth, and Hims & Hers Health (NYSE: HIMS) is right at the eye of the storm. They've gone from a darling of digital health to a pariah faster than you can say 'data breach.' On July 29, 2026, they took a hit so hard you’d think the company stepped into the ring with a heavyweight...

India's First Upright Proton Therapy System Unveiled

A Leap Forward in Cancer Care: Proton Therapy Revolution Dang, just when you think you've heard it all in cancer treatment, Fortis Healthcare drops a bombshell: India’s first upright proton therapy system. Boom! This isn't your run-of-the-mill radiation treatment we're talking about here. This is the futuristic flair of the MEVION S250-FIT™, featuring upright...

Jollibee and DreamWorks Unite for Cultural Celebration

Jollibee Partners with DreamWorks Animation Never thought I’d see the day: Jollibee, that familiar face of fast food, teaming up with the creative juggernaut DreamWorks Animation. They’re calling it a celebration of friendship and Filipino culture, wrapped up neatly in the context of a flick called Forgotten Island. Set to sizzle in theaters on September 25, 2026,...

Innventure Faces Major Lawsuit Amidst Market Turmoil

The Plot Thickens with Innventure's DarkNX Project Buckle up, fellow market sling-riders; the Innventure tale is a rocky one for the books. Imagine this: You’ve plunked down your hard-earned cash on Innventure Inc. (NASDAQ: INV), lured by their glowing pronouncements about a supposed golden egg project, the Accelsius DarkNX data-center deal. A big talk about...

Tiger Group to Auction Huge Window Manufacturing Plant

Glass & Vinyl Ambitions: A New Chapter Who would have guessed? The seasoned window maker Showcase Window and Door Company is putting its prime manufacturing facility up for grabs. The online auction, orchestrated by Tiger Group, kicks off September 10, and it's sure to stir up some excitement in the industry. With picking up operations now within reach, it feels like...